India: market value of leading brand in the cardiac segment 2020

Market value of leading brand in the cardiac segment across India in financial year 2020 (in billion Indian rupees)

Market value of leading brand in the cardiac segment India FY 2020

Last update:

Feb 8, 2021

Author:

��ƽ�� Research Department

Region:

India

Survey time period:

From 01/01/2020 to 31/12/2020

Ticagrelor was the leading fastest growing molecule in the cardiac segment in the Indian pharmaceutical market with a market value of over three billion Indian rupees in financial year 2020. JB Chemicals, Lupin and Cadila companies had a strong presence in top ten fastest growing molecules that year.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Market value of leading brand in the cardiac segment across India in financial year 2020 (in billion Indian rupees)

Get in touch with us for additional information

��ƽ��